Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial

出版年份 2015 全文链接

标题

作者

关键词

出版物

Volume 16, Issue 2, Pages 169-176

出版商

Elsevier BV

发表日期

2014-12-31

DOI

10.1016/s1470-2045(14)71182-9

Discuss science. Find collaborators. Network.

Join a conversation

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started